Repligen Corporation (RGEN)
USD 147.34
(-6.83%)
USD 147.34
(-6.83%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 124.29 Million USD | -28.82% |
| 2022 | 246.92 Million USD | 7.36% |
| 2021 | 211.56 Million USD | 147.02% |
| 2020 | 101.62 Million USD | 94.61% |
| 2019 | 58.43 Million USD | 36.26% |
| 2018 | 41.76 Million USD | 97.1% |
| 2017 | 24.14 Million USD | -27.45% |
| 2016 | 24.55 Million USD | 5.48% |
| 2015 | 22.44 Million USD | 34.37% |
| 2014 | 15.15 Million USD | -43.33% |
| 2013 | 26.12 Million USD | 100.36% |
| 2012 | 14.83 Million USD | 777.09% |
| 2011 | -30.47 Thousand USD | 129.64% |
| 2010 | 1.65 Million USD | -188.51% |
| 2009 | -3.51 Million USD | 190.05% |
| 2008 | 6.85 Million USD | -146.43% |
| 2007 | 36.71 Million USD | -12.19% |
| 2006 | -1.82 Million USD | 56.55% |
| 2005 | -1.22 Million USD | 34.82% |
| 2004 | -2.22 Million USD | -44.98% |
| 2003 | -8.66 Million USD | 24.67% |
| 2002 | -4.29 Million USD | 29.33% |
| 2001 | -5.32 Million USD | -150.26% |
| 2000 | -7.05 Million USD | -1719.96% |
| 1999 | -4.03 Million USD | 66.67% |
| 1998 | -2.45 Million USD | -50.0% |
| 1997 | -615.02 Thousand USD | 85.71% |
| 1996 | -2.8 Million USD | 56.25% |
| 1995 | -6.4 Million USD | 61.9% |
| 1994 | -17.7 Million USD | -75.0% |
| 1993 | -16.8 Million USD | 17.95% |
| 1992 | -9.6 Million USD | -15.84% |
| 1991 | -11.7 Million USD | -58.11% |
| 1990 | -7.4 Million USD | -335.29% |
| 1989 | -1.7 Million USD | 39.29% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 20.21 Million USD | 45.79% |
| 2024 Q1 | 15.5 Million USD | -4.06% |
| 2023 FY | - USD | -28.82% |
| 2023 Q2 | 21.26 Million USD | -33.79% |
| 2023 Q4 | 19.61 Million USD | 167.54% |
| 2023 Q3 | -29.04 Million USD | -236.63% |
| 2023 Q1 | 32.11 Million USD | -0.01% |
| 2022 Q4 | 32.11 Million USD | -42.63% |
| 2022 FY | - USD | 7.36% |
| 2022 Q2 | 64.53 Million USD | -5.88% |
| 2022 Q1 | 68.56 Million USD | 56.13% |
| 2022 Q3 | 55.98 Million USD | -13.25% |
| 2021 Q1 | 36.15 Million USD | 102.72% |
| 2021 Q4 | 43.91 Million USD | -19.3% |
| 2021 Q3 | 54.41 Million USD | 14.66% |
| 2021 Q2 | 47.46 Million USD | 31.26% |
| 2021 FY | - USD | 147.02% |
| 2020 Q1 | 18.67 Million USD | 233.36% |
| 2020 Q4 | 17.83 Million USD | -34.96% |
| 2020 Q3 | 27.42 Million USD | 8.61% |
| 2020 FY | - USD | 94.61% |
| 2020 Q2 | 25.25 Million USD | 35.19% |
| 2019 Q2 | 15.19 Million USD | -3.46% |
| 2019 FY | - USD | 36.26% |
| 2019 Q1 | 15.74 Million USD | 98.56% |
| 2019 Q4 | 5.6 Million USD | -60.03% |
| 2019 Q3 | 14.01 Million USD | -7.76% |
| 2018 Q4 | 7.92 Million USD | -31.85% |
| 2018 FY | - USD | 97.1% |
| 2018 Q1 | 10 Million USD | 220.43% |
| 2018 Q2 | 8.45 Million USD | -15.48% |
| 2018 Q3 | 11.63 Million USD | 37.54% |
| 2017 Q1 | 7.13 Million USD | 142.05% |
| 2017 Q2 | 6.84 Million USD | -4.16% |
| 2017 Q3 | 2.59 Million USD | -62.14% |
| 2017 Q4 | 3.12 Million USD | 20.58% |
| 2017 FY | - USD | -27.45% |
| 2016 FY | - USD | 5.48% |
| 2016 Q1 | 5.63 Million USD | 80.33% |
| 2016 Q2 | 7.88 Million USD | 39.85% |
| 2016 Q3 | 5.72 Million USD | -27.39% |
| 2016 Q4 | 2.94 Million USD | -48.5% |
| 2015 Q3 | 5.03 Million USD | -19.47% |
| 2015 Q2 | 6.25 Million USD | 18.37% |
| 2015 Q4 | 3.12 Million USD | -37.91% |
| 2015 Q1 | 5.28 Million USD | 146.75% |
| 2015 FY | - USD | 34.37% |
| 2014 Q3 | 2.21 Million USD | -46.71% |
| 2014 Q1 | 6.3 Million USD | 21.78% |
| 2014 Q2 | 4.15 Million USD | -34.11% |
| 2014 Q4 | 2.14 Million USD | -3.22% |
| 2014 FY | - USD | -43.33% |
| 2013 Q2 | 6.01 Million USD | 70.9% |
| 2013 Q4 | 5.17 Million USD | -41.9% |
| 2013 Q1 | 3.52 Million USD | -46.96% |
| 2013 FY | - USD | 100.36% |
| 2013 Q3 | 8.9 Million USD | 48.04% |
| 2012 Q3 | 2.28 Million USD | 73.69% |
| 2012 Q4 | 6.63 Million USD | 189.96% |
| 2012 Q1 | 1.16 Million USD | 0.0% |
| 2012 Q2 | 1.31 Million USD | 12.91% |
| 2012 FY | - USD | 777.09% |
| 2011 FY | - USD | 129.64% |
| 2011 Q4 | - USD | -100.0% |
| 2011 Q2 | -187.46 Thousand USD | 88.88% |
| 2011 Q1 | -1.68 Million USD | -321.34% |
| 2011 Q3 | 500.17 Thousand USD | 366.81% |
| 2010 Q3 | 933.74 Thousand USD | -27.68% |
| 2010 FY | - USD | -188.51% |
| 2010 Q4 | 761.81 Thousand USD | -18.41% |
| 2010 Q1 | -1.37 Million USD | -33.64% |
| 2010 Q2 | 1.29 Million USD | 193.79% |
| 2009 Q3 | -1.1 Million USD | 0.15% |
| 2009 Q1 | -1.39 Million USD | -91.46% |
| 2009 FY | - USD | 190.05% |
| 2009 Q2 | -1.1 Million USD | 21.06% |
| 2009 Q4 | -1.03 Million USD | 6.64% |
| 2008 Q2 | 7.66 Million USD | 278.08% |
| 2008 FY | - USD | -146.43% |
| 2008 Q1 | -4.3 Million USD | -177.59% |
| 2008 Q3 | -578.54 Thousand USD | -107.55% |
| 2008 Q4 | -731.15 Thousand USD | -26.38% |
| 2007 FY | - USD | -12.19% |
| 2007 Q3 | -75.75 Million USD | -91007.79% |
| 2007 Q2 | -83.14 Thousand USD | 81.27% |
| 2007 Q4 | -1.55 Million USD | 97.95% |
| 2007 Q1 | -443.98 Thousand USD | -21.72% |
| 2006 Q4 | -364.74 Thousand USD | 69.71% |
| 2006 FY | - USD | 56.55% |
| 2006 Q1 | -330.34 Thousand USD | 37.28% |
| 2006 Q2 | 3895.00 USD | 101.18% |
| 2006 Q3 | -1.2 Million USD | -31018.38% |
| 2005 FY | - USD | 34.82% |
| 2005 Q4 | -526.73 Thousand USD | 10.14% |
| 2005 Q3 | -586.19 Thousand USD | -194.41% |
| 2005 Q2 | -199.11 Thousand USD | 77.43% |
| 2005 Q1 | -882.06 Thousand USD | 46.83% |
| 2004 Q2 | -445.17 Thousand USD | 49.65% |
| 2004 Q1 | -884.07 Thousand USD | 57.42% |
| 2004 Q3 | -1.59 Million USD | -258.64% |
| 2004 Q4 | -1.65 Million USD | -3.91% |
| 2004 FY | - USD | -44.98% |
| 2003 Q2 | -1.88 Million USD | -19.69% |
| 2003 FY | - USD | 24.67% |
| 2003 Q4 | -1.97 Million USD | 0.29% |
| 2003 Q3 | -1.98 Million USD | -4.75% |
| 2003 Q1 | -1.56 Million USD | -100.47% |
| 2002 Q4 | -688.02 Thousand USD | 30.57% |
| 2002 FY | - USD | 29.33% |
| 2002 Q1 | -1.09 Million USD | -1.34% |
| 2002 Q2 | -998.12 Thousand USD | 10.52% |
| 2002 Q3 | -1.03 Million USD | -2.29% |
| 2001 Q4 | -1.02 Million USD | 32.2% |
| 2001 Q3 | -1.59 Million USD | 2.63% |
| 2001 Q2 | -1.6 Million USD | -6.92% |
| 2001 Q1 | -1.62 Million USD | 27.97% |
| 2001 FY | - USD | -150.26% |
| 2000 Q3 | -1.71 Million USD | -18.77% |
| 2000 Q2 | -1.39 Million USD | -149.2% |
| 2000 FY | - USD | -1719.96% |
| 2000 Q1 | -765.94 Thousand USD | 52.13% |
| 2000 Q4 | -1.98 Million USD | -11.63% |
| 1999 Q2 | -396 Thousand USD | -133.33% |
| 1999 FY | - USD | 66.67% |
| 1999 Q1 | -300 Thousand USD | 325.0% |
| 1999 Q4 | -1.6 Million USD | -128.57% |
| 1999 Q3 | -700 Thousand USD | -133.33% |
| 1998 Q2 | -300 Thousand USD | 0.0% |
| 1998 Q1 | -300 Thousand USD | -400.0% |
| 1998 Q3 | -200 Thousand USD | 33.33% |
| 1998 FY | - USD | -50.0% |
| 1998 Q4 | -300 Thousand USD | -100.0% |
| 1997 Q4 | - USD | 133.33% |
| 1997 Q3 | -300 Thousand USD | -400.0% |
| 1997 Q2 | - USD | 200.0% |
| 1997 Q1 | -100 Thousand USD | 0.0% |
| 1997 FY | - USD | 85.71% |
| 1996 FY | - USD | 56.25% |
| 1996 Q4 | -100 Thousand USD | -133.33% |
| 1996 Q3 | 300 Thousand USD | 160.0% |
| 1996 Q2 | -500 Thousand USD | 70.59% |
| 1996 Q1 | -1.7 Million USD | 15.0% |
| 1995 Q1 | -2.1 Million USD | 260.78% |
| 1995 FY | - USD | 61.9% |
| 1995 Q4 | -2 Million USD | -233.33% |
| 1995 Q3 | -600 Thousand USD | 72.73% |
| 1995 Q2 | -2.2 Million USD | -126.83% |
| 1994 FY | - USD | -75.0% |
| 1994 Q4 | -5.1 Million USD | -21.43% |
| 1994 Q2 | -5.2 Million USD | -36.84% |
| 1994 Q1 | -3.8 Million USD | 20.83% |
| 1994 Q3 | -5.2 Million USD | 19.23% |
| 1993 Q3 | -4.1 Million USD | 21.15% |
| 1993 Q4 | -4.8 Million USD | -17.07% |
| 1993 Q2 | -4.5 Million USD | -5300.0% |
| 1993 Q1 | 100 Thousand USD | 101.39% |
| 1993 FY | - USD | 17.95% |
| 1992 Q3 | -4 Million USD | -611.11% |
| 1992 Q4 | -5.5 Million USD | -56.52% |
| 1992 FY | - USD | -15.84% |
| 1992 Q1 | -400 Thousand USD | 94.81% |
| 1992 Q2 | 900 Thousand USD | 325.0% |
| 1991 Q2 | -1.2 Million USD | 69.23% |
| 1991 Q1 | -3.9 Million USD | -225.0% |
| 1991 FY | - USD | -461.11% |
| 1991 Q3 | -1.9 Million USD | -58.33% |
| 1991 Q4 | -7.7 Million USD | -305.26% |
| 1990 Q2 | -1.1 Million USD | 89.91% |
| 1990 Q4 | -1.2 Million USD | 0.0% |
| 1990 FY | - USD | 35.71% |
| 1990 Q3 | -1.2 Million USD | -9.09% |
| 1990 Q1 | -10.9 Million USD | -402.78% |
| 1989 FY | - USD | -27.27% |
| 1989 Q4 | 3.6 Million USD | 33.33% |
| 1989 Q3 | 2.7 Million USD | 8.0% |
| 1989 Q2 | 2.5 Million USD | 125.77% |
| 1989 Q1 | -9.7 Million USD | -459.26% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Akoya Biosciences, Inc. | -45.63 Million USD | 372.379% |
| AngioDynamics, Inc. | -14.29 Million USD | 969.661% |
| AtriCure, Inc. | -8.1 Million USD | 1632.766% |
| Avinger, Inc. | -16.34 Million USD | 860.382% |
| Azenta, Inc. | 55.15 Million USD | -125.367% |
| BioLife Solutions, Inc. | -45.23 Million USD | 374.751% |
| The Cooper Companies, Inc. | 882.8 Million USD | 85.921% |
| Daxor Corporation | 329.74 Thousand USD | -37593.941% |
| Ekso Bionics Holdings, Inc. | -13.19 Million USD | 1041.749% |
| Femasys Inc. | -13.16 Million USD | 1043.793% |
| GlucoTrack, Inc. | -7.09 Million USD | 1852.813% |
| Harvard Bioscience, Inc. | 9.49 Million USD | -1209.302% |
| Hologic, Inc. | 1.29 Billion USD | 90.411% |
| ICU Medical, Inc. | 307.69 Million USD | 59.605% |
| Intuitive Surgical, Inc. | 2.39 Billion USD | 94.808% |
| KORU Medical Systems, Inc. | -9.39 Million USD | 1422.313% |
| LeMaitre Vascular, Inc. | 48.99 Million USD | -153.709% |
| Innovative Eyewear, Inc. | -6.57 Million USD | 1990.334% |
| Innovative Eyewear, Inc. | -6.57 Million USD | 1990.334% |
| Masimo Corporation | 236.7 Million USD | 47.49% |
| Microbot Medical Inc. | -10.63 Million USD | 1268.817% |
| Meihua International Medical Technologies Co., Ltd. | 15.77 Million USD | -688.127% |
| Merit Medical Systems, Inc. | 231.44 Million USD | 46.297% |
| Nephros, Inc. | -1.37 Million USD | 9113.198% |
| NovoCure Limited | -175.86 Million USD | 170.675% |
| NEXGEL, Inc. | -2.73 Million USD | 4652.821% |
| NEXGEL, Inc. | -2.73 Million USD | 4652.821% |
| Singular Genomics Systems, Inc. | -86.49 Million USD | 243.697% |
| OraSure Technologies, Inc. | 76.15 Million USD | -63.203% |
| Pro-Dex, Inc. | 8.33 Million USD | -1391.564% |
| Pulse Biosciences, Inc. | -42.36 Million USD | 393.37% |
| Predictive Oncology Inc. | -13.18 Million USD | 1042.891% |
| Precision Optics Corporation, Inc. | -2.51 Million USD | 5048.026% |
| QuidelOrtho Corporation | 545.6 Million USD | 77.219% |
| Sanara MedTech Inc. | -289.09 Thousand USD | 43093.182% |
| STAAR Surgical Company | 33.22 Million USD | -274.137% |
| Sharps Technology, Inc. | -8.98 Million USD | 1484.038% |
| Utah Medical Products, Inc. | 24.8 Million USD | -401.076% |
| DENTSPLY SIRONA Inc. | 232 Million USD | 46.426% |
| Jin Medical International Ltd. | 3.44 Million USD | -3510.112% |